Antihistamines and Driving-Related Behavior: A Review of the Evidence for Impairment
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Antihistamines and Driving-Related Behavior: A Review of the Evidence for Impairment

Filetype[PDF-17.40 MB]


Select the Download button to view the document
This document is over 5mb in size and cannot be previewed
English
Details You May Also Like

Details:

  • Creators:
    Moskowitz, Herbert, 1925-
  • Corporate Contributors:
    United States. Department of Transportation. National Highway Traffic Safety Administration
  • Subject/TRT Terms:
  • Publication/ Report Number:
  • DOI:
  • Resource Type:
    Research Paper
  • Geographical Coverage:
    United States
  • Edition:
    Final report
  • Corporate Publisher:
    United States. Department of Transportation. National Highway Traffic Safety Administration
  • Abstract:
    A review of the scientific literature concerning the effects of antihistamines on driving-related skills was conducted. After reviewing all pertinent publications from 1998 and earlier, a total of 130 publications were found to meet criteria for inclusion in the data summaries. A data base was created with study results being indexed, and summarized, by specific drug, dose, dosing schedule (i.e., single versus repeated) and H1-antagonist generation as well as by behavioral area or subjective measure. For each H1-antagonist generation, five drugs were evaluated: chlorpheniramine, clemastine, diphenhydramine, hydroxyzine and tripolidine for the 1st-generation, and astemizole, cetirizine, fexofenadine, loratadine and terfenadine for the 2nd-generation. It was concluded that: (1) There is some slight, but ambiguous, evidence from epidemiological studies of a connection between antihistamine use and traffic collision rates. However, these studies were done primarily when use of only 1st-generation (but not 2nd-generation) antihistamines was prevalent; thus, more study is needed. (2) There is overwhelming evidence from the experimental literature that the 1st-generation antihistamines produce objective signs of skills performance impairment as well as subjective symptoms of sedation. (3) While 2nd-generation antihistamines represent a major triumph for the pharmaceutical industry in reducing potential side effects, there still remains some evidence that all antihistamines, even the 2nd-generation drugs, may cause sedation and objective skills impairment at least in some cases and for some individuals. (4) Within both the 1st- and 2nd-generation antihistamine groupings, there is considerable variation in objective evidence of impairment and in subjective effects such as sedation. Thus, there clearly are drugs that are to be preferred for use to avoid side effects such as sedation and driving-related performance impairment. (5) Methodologically, it is apparent that among the many diverse techniques for investigating driving-related impairment, some methods and behavioral domains are more sensitive to the effects of antihistamines. Future studies of antihistamines, therefore, must utilize the most methodologically-sound techniques so as to permit a better comparison between different drugs.
  • Format:
    PDF
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at rosap.ntl.bts.gov